This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Palio Receives The Vision Award

SARATOGA SPRINGS, N.Y., April 28 /PRNewswire-FirstCall/ -- Palio, an inVentiv Health (Nasdaq: VTIV) company, is pleased to announce that it received the 2010 Vision Award, a distinguished award by Med Ad News a business newsmagazine for the pharmaceutical business and marketing community. The Vision Award best demonstrates the healthcare ad agency of the future: recognizing agencies for efforts that have the greatest potential to transform the industry in a positive way.

Each year, Med Ad News recognizes excellence among the top advertising agencies in the United States, in areas ranging from most creative to best professional Web site. Winners of the 2010 competition were announced at the 21st Annual Manny Awards on April 22.

"This nomination is an incredible testament to what we have accomplished and continue to accomplish here in Saratoga," said Mike Myers, president of Palio. "I need to thank the spirit and enthusiasm of our talented employees and partners who led to the award itself. And our clients, who give us the opportunity to produce great work on the brands we support. It's the incredible people we work with every day that makes receiving such prestigious recognitions so gratifying."

The Vision Award recognizes Palio's award-winning efforts and leadership position in the social media space; their partnership with Zemoga, which resulted in the groundbreaking interactive offering Pixels & Pills; the launch of Health Tweeder ( www.healthtweeder.com), a dynamic health-focused Twitter aggregator; and the development of Susurro, a proprietary research study that monitors social media dialogue for pharmaceutical brands.

"This award acknowledges that the change we are driving is a necessity for our industry and our clients," said Guy Mastrion, chief global creative officer at Palio. "Digital technologies and digital media will continue to change and improve and as an industry we must lead the evolution in order to build our clients brands to result in the best outcome."

Palio is a full-spectrum advertising and communications agency headquartered in Saratoga Springs, NY, that excels in brand creation that changes the way people think with execution that will Never be forgotten(SM). For more information on Palio, visit www.palio.com.

About the Manny Awards

For more than 20 years, the Med Ad News Manny Awards have paid tribute to the creative work of agencies serving the healthcare market, their people, and their contributions to the industry. Each year at this gala awards ceremony, Med Ad News and agency professionals come together to celebrate creative excellence in pharmaceutical and medical device advertising and to acknowledge those making significant contributions to healthcare communications. On this special evening, more than 600 industry peers are anticipated to join Med Ad News in honoring winners in a range of award categories.

About Med Ad News

The pharmaceutical industry's publication of record for more than 25 years, Med Ad News provides broad coverage and incisive analysis of the issues, events, trends, and strategies shaping pharmaceutical business, marketing, and sales. More than 16,500 readers – comprising corporate executives, marketing, sales, and product managers – receive Med Ad News 12 times per year. Med Ad News is a publication of Canon Communications Pharmaceutical Media Group.

SOURCE Palio

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs